GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Home・Akciju saraksts・BioArctic AB

B
BioArctic AB

Slēgts

290 -7.29

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

272.2

Max

312.8

Galvenie mērījumi
By Trading Economics
Ienākumi	-979M 97M
Pārdošana	-897M 392M
P/E Sektora vidējais	25.665 35.733
EPS	1.09
Peļņas marža	24.623
Darbinieki	119
EBITDA	1.1B 1.1B

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	6.6B 27B
Iepriekšējā atvēršanas cena	297.29
Iepriekšējā slēgšanas cena	290

BioArctic AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 5. sept. 16:09 UTC

Iegādes, apvienošanās, pārņemšana

BBVA Clears Last Hurdle to Open $17.4 Billion Bid to Sabadell Shareholders -- 2nd Update

2025. g. 5. sept. 20:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 5. sept. 20:37 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Assets of Auction Include Nationwide Retail Distribution Network of More Than 4,000 Branded Service Stations >BLUWU

2025. g. 5. sept. 20:37 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Assets of Auction Include Lubricant and Blending Plants Supporting Specialty Fuels and Lubricants >BLUWU

2025. g. 5. sept. 20:36 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Assets of Auction Include Midstream Infrastructure, Including Pipelines and Terminals Such as the Sour Lake Crude Pipeline >BLUWU

2025. g. 5. sept. 20:36 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Assets of Auction Include Refineries at Lake Charles, La., Lemont, Ill., Corpus Christi, Texas, With Combined Refining Capacity Exceeding 800,000 Barrels per Day >BLUWU

2025. g. 5. sept. 20:33 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Proposal Would Provide $3.2B Settlement for Holders of PDVSA 2020 Bonds to Be Paid Either in Cash or in Shrs of Publicly Listed Entity That Will Own Citgo >BLUWU

2025. g. 5. sept. 20:33 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water: Proposal Would Provide Cash or Stk Distributions to PDV Holding Inc.'s General Creditors >BLUWU

2025. g. 5. sept. 20:31 UTC

Iegādes, apvienošanās, pārņemšana

Blue Water Acquisition Corp. III: Announces Submission of $10B Bid for PDV Holding Inc., Parent of Citgo Petroleum Corp.

2025. g. 5. sept. 20:20 UTC

Peļņas

These Stocks Moved the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

2025. g. 5. sept. 19:23 UTC

Tirgus saruna

Oil Futures Extend Losses Ahead of OPEC+ Meeting -- Market Talk

2025. g. 5. sept. 19:22 UTC

Peļņas

Week's Best: Insurance Costs, Like Sea Levels, Are Rising -- Barrons.com

2025. g. 5. sept. 19:17 UTC

Tirgus saruna

U.S. Natural Gas Snaps Winning Streak -- Market Talk

2025. g. 5. sept. 18:59 UTC

Peļņas

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

2025. g. 5. sept. 18:35 UTC

Tirgus saruna

BMO Leans Toward September Canada Rate Cut After 'Exceptionally Weak' Jobs Report -- Market Talk

2025. g. 5. sept. 17:25 UTC

Tirgus saruna

Bets on Hefty Fed Cut Seen as Exaggerated -- Market Talk

2025. g. 5. sept. 17:20 UTC

Tirgus saruna

U.S. Oil Rig Count Rises By 2 to 414 -- Market Talk

2025. g. 5. sept. 17:17 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 5. sept. 17:17 UTC

Tirgus saruna

Bank of Canada Policy Seen Moving to Expansionary Territory -- Market Talk

2025. g. 5. sept. 17:03 UTC

Tirgus saruna

Bank of Canada Expected to Cut, But Inflationary Pressures Remain a Concern -- Market Talk

2025. g. 5. sept. 16:39 UTC

Iegādes, apvienošanās, pārņemšana

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

2025. g. 5. sept. 16:39 UTC

Iegādes, apvienošanās, pārņemšana

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

2025. g. 5. sept. 16:39 UTC

Iegādes, apvienošanās, pārņemšana

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

2025. g. 5. sept. 16:39 UTC

Iegādes, apvienošanās, pārņemšana

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

2025. g. 5. sept. 16:37 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Equities Roundup: Market Talk

2025. g. 5. sept. 16:37 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Energy Roundup: Market Talk

2025. g. 5. sept. 16:37 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Strathcona Buys Up More MEG Shares In Effort to Scuttle Cenovus Deal -- Market Talk

2025. g. 5. sept. 16:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 5. sept. 16:16 UTC

Peļņas

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Guidewire, and More -- Barrons.com

2025. g. 5. sept. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

BioArctic AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.